Search
for
Sort by
Research 31–60 of 1000+
- Approaches to management of endocrine therapy–induced alopecia in breast cancer patients
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Safety of testosterone treatment in postmenopausal women
- Safety of testosterone use in women
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- The role of androgens in hormone replacement therapy
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- Hormonal contraceptives: pharmacology tailored to women's health
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- Association of Spironolactone Use With Risk of Cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Abstract PS1-04-01: Misguided Relief: Prevalence and Patterns of Symptom Management Misinformation for Breast Cancer on Instagram
- Ductal breast cancer in a male patient
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- The Role of Herbal Medicine in Breast Cancer Treatment: Evidence for Therapeutic Effectiveness
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer